Finance

Lists
SGRY:NASDAQ
Surgery Partners Inc
$26.78
+0.34%
(+0.090) 1D
$26.78
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SGRY...
Open
$26.64
High
$26.96
Low
$26.62
Mkt. cap
3.50B
Avg. vol.
5.72M
Volume
1.11M
52-wk high
$27.22
52-wk low
$11.41
EPS
-$0.68
Beta
1.85
Shares outstanding
130.88M
No. of employees
16K
Open
$26.64
High
$26.96
Low
$26.62
Mkt. cap
3.50B
Avg. vol.
5.72M
Volume
1.11M
52-wk high
$27.22
52-wk low
$11.41
EPS
-$0.68
Beta
1.85
Shares outstanding
130.88M
No. of employees
16K
News stories
From web sources and news partners
About Surgery Partners Inc
CEO-
Employees16K
Founded2004
Headquarters-
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 8 analysts giving stock ratings to SGRY in the past 3 months
Hold
Buy
1
Hold
7
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for SGRY in the last 3 months.
Highest
Current $26.78
$25.00 (-6.65%)
Average
$21.38 (-20.16%)
Lowest
$14.00 (-47.72%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Hold
Maintained
$25.00
-6.6%
11/11/2026
Ann Hynes
Mizuho Securities
Hold
Downgraded
$25.00
-6.6%
11/11/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$25.00
-6.6%
11/09/2026
A.J. Rice
UBS
Hold
Downgraded
$23.50
-12.2%
10/27/2026
Sarah James
Cantor Fitzgerald
Hold
Downgraded
$23.50
-12.2%
10/26/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$14.00
-47.7%
10/07/2026
Joanna Gajuk
Bank of America Securities
Buy
Reiterated
$20.00
-25.3%
09/18/2026
Benjamin Rossi
J.P. Morgan
Hold
Reiterated
$15.00
-44%
09/14/2026
Bill Sutherland
StoneX
Buy
Reiterated
$24.00
-10.4%
08/11/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
08/11/2026
Gary Taylor
TD Cowen
Buy
Reiterated
$19.00
-29.1%
08/11/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$17.00
-36.5%
05/06/2026
Last report
Nov 9, 2026
Fiscal period
Q3 2026
$0.16 / $0.13
+25.77%beat
Revenue / Est. (USD)
815.30M / 814.70M
+0.07%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
885.00M
810.90M
848.90M
815.30M
Cost of goods sold
672.80M
650.70M
658.70M
630.30M
Cost of revenue
672.80M
650.70M
658.70M
630.30M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.70M
39.30M
36.30M
40.60M
Operating expense
78.70M
76.10M
73.70M
76.20M
Total operating expenses
751.50M
726.80M
732.40M
706.50M
Operating income
133.50M
84.10M
116.50M
108.80M
Other non operating income
8.10M
-
1.40M
1.50M
EBT including unusual items
42.60M
-3.30M
32.30M
17.70M
EBT excluding unusual items
72.50M
19.10M
53.10M
47.30M
Income tax expense
13.60M
-1.20M
2.60M
3.60M
Effective tax rate
31.92%
36.36%
8.05%
20.34%
Other operating expenses
-4.90M
-1.70M
-1.90M
-4.00M
Net income
-15.00M
-35.90M
-15.00M
-21.10M
Net profit margin
-1.69%
-4.43%
-1.77%
-2.59%
Earnings per share
0.12
-0.03
0.10
0.16
Interest and investment income
-
-
-
-
Interest expense
-75.70M
-69.10M
-71.20M
-69.40M
Net interest expenses
-75.70M
-69.10M
-71.20M
-69.40M
Depreciation and amortization charges
59.90M
38.50M
39.30M
39.60M
EBITDA
193.40M
122.60M
155.80M
148.40M
Gain or loss from assets sale
11.40M
4.30M
2.40M
2.90M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps